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The infusion of hemoglobin solutions to replace lost blood has been tested in 
experiments on both animals  (2-15)  and man  (4,  16-19).  Beneficial results 
have been obtained in restoring the volume of circulating blood, in carrying 
oxygen to the tissues (3), and in supplying iron for regeneration of erythrocytes 
and nitrogen for regeneration of blood and tissue proteins (12).  For infusions 
hemoglobin solutions have advantages over whole blood in that the former do 
not need to be typed and cross-matched, and that longer preservation is pos- 
sible.  However, in both patients and'~mlmMs,  some of the infusions have been 
followed by unfavorable results, particularly on the kidneys.  It has appeared 
uncertain whether these effects have been due to injury by the hemoglobin 
itself, caused during its rather rapid excretion through the kidneys, to admiT- 
ture of methemoglobin with  the  active hemoglobin  (hemoglobin capable  of 
reversible combination with oxygen), to the presence of cell stroma material 
in the hemoglobin solutions used, or to bacterial contamination or products. 
The present work was undertaken to provide a  method whereby large vol- 
umes of hemoglobin solution could be prepared in  a  sterile state,  free from 
stroma  material,  of  electrolyte content  approximating  that  of  plasma,  and 
capable of preservation without change of the active hemoglobin to methemo- 
globin. 
Analytical Methods and Tests 
The carbon monoxide-blnding capacity of the hemoglobin  solutions was determined by a 
modification of the method of Van Slyke  and Hiller (20) described by Van Slyke, Hiller, 
* The work described  in this paper was done under a contract, recommended  by the Com- 
mittee on Medical Research, between the Offic  e of Scientific  Research and Development  and 
The Rockefeller  Institute for Medical Research. 
The Bureau of Medicine and Surgery of the United States Navy does not necessarily 
undertake to endorse views or opinions which are expressed  in this paper. 
§ Reported in abstract at meetings  of the Federated Societies  for Experimental  Biology  and 
Medicine, Atlantic City, New Jersey, March 14, 1946 (1). 
H  On leave of absence from Alfred L duPont Institute  of the Nemours Foundation, Wil- 
mington, Delaware. 
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Weisiger, and Cruz (21).  The hemoglobin fraction capable of binding carbon monoxide is 
hereafter designated as "active hemoglobin." 
Total hemoglobin content of the solutions was determined by the above carbon monoxide 
capacity method after reduction of the solution with sodium hyposulfite (NasSsO4) according 
to the modification  of the method of Van Slyke and Hiller (22) described by Van Slyke, Hiller, 
Weisiger,  and Cruz (21). 
The difference  between the total hemoglobin content of the solutions and the  active 
hemoglobin content gives the inactive hemoglobin fraction hereafter designated as methemo- 
globin. 
Toted lipid content of the solutions  was determined by extraction of the lipids by the method 
of Folch and Van Slyke (23) and subsequent estimation of the extracted lipids by determining 
their carbon by the method of Van Slyke and Folch (24). 
The pH of the preparations was determined by the glass electrode. 
Sodium and potassium concentrations of solutions were determined with a  flame photo- 
meter  (25). 1 
Tests for pyrogenie substances, for which we are indebted to Dr. R. B. Penner of Sharp 
and Dohme Company, were carried out in accordance with the directions of the g. S. Pharma- 
copoeia XII  (26). 
Sterility tests were carried out by culturing 5 ml. aliquots aerobically and anaerobically. 
We are indebted to Dr. Frank Horsfali, Jr., of the Rockefeller  Institute Hospital for most of 
these tests and to Dr. Pennell of Sharp and Dohme for the remainder. 
Toxicity tests were carried out on all earlier preparations.  One half ml. of the solution to 
be tested was injected intraperitoneally into each of ten 15 gin. Swiss mice.  The criterion 
was survival  For later preparations, made after experience  gained with the solutions, this 
test was omitted; but in other experiments the effects of administration to dogs in large quan- 
tities intravenously provided evidence for the absence of toxicity factors. 
Preparation of Hemoglobin Solutions 
The  procedure  consisted  of  the  following  steps:  (1)  laking  the  cells  with 
water,  (2)  precipitation of  the  stroma  material by acidifying to pH  5.7-5.8, 
(3) ion exchange of most of the potassium for sodium by treatment with sodium 
zeolite,  (4)  removal  of  stroma  and zeolite by centrffugation,  (5)  addition of 
NaC1  and  NaHCO3  to  obtain physiological  salt  concentration  and pH,  (6) 
terilization by filtration through a Seitz filter. 
s 
General Measures to Insure Sterility.--Throughout  the procedures required in the prepara- 
tion of the solutions a strict aseptic technique was followed.  All containers were sterilized 
by autoclaving prior to use.  When a vessel was opened to receive a solution, the mouth was 
flamed, and the flaming was repeated before reinsertion of the sterile plug used as a stopper. 
All water used in preparations was freshty double distilled under conditions  making it pyrogen- 
free.  Salts were added to solution~ immediately before passage through a  Seitz sterilizing 
filter.  All procedures were carried~ut at 4°C., and the solutions were stored at 4°C., unless 
otherwise stated.  Cultures for aerobic and anaerobic organisms were taken prior to passage 
through the Seitz sterilizing filter.  Bacterial contamination of the solution at this point was 
x We are greatly indebted to Dr. R. Bowling Barnes and Dr. J. W. Berry of the American 
Cyanamid Company, Stamford, Connecticut, for the extended use of one of their own re- 
search models of the flame photometer, considerably in advance of detailed publication or 
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never encountered.  The sterility tests were repeated on solutions just prior to use in phy- 
siological experiments.  Specific procedures are detailed below. 
Source of Red Blood Cells.--Red blood cell residues discarded from Red Cross donor centers  2 
after withdrawal of plasma were used for making human hemoglobin solutions.  Solutions of 
dog hemoglobin were made by bleeding dogs, heparinizing the blood, sterilely aspirating the 
plasma after centrifugation, and utilizing the residues in the same manner as with human 
blood. 
Laking of Red Blood Cells and Precipitation of Stroma Mater/a/.--One volume of fresh red 
blood cell residues was suspended in an equal volume of sterile isotonic saline and repacked by 
centrifugstion for 30 minutes at 3000  R.P.M.  The supernatant  fluid and buffy layer were 
aspirated off with aseptic technique and discarded.  One volume of washed cell residue was 
then laked by mixing and standing for 1 hour with two volumes of distilled water.  Tenth 
normal HC1 was then added in small portions, usually ten, until the pH of the mixture fell 
to 5.7-5.8.  Approximately 0.6 volume of acid was needed, and it was convenient to add 0.5 
volume of acid before determining the pH.  During the addition of the acid, the mixture was 
stirred by swirling the contents of the flask but violent mechanical agitation was avoided; this 
procedure produced a bulky precipitate which filtered off readily.  Mter addition of the acid, 
the solution was made up to a volume equal to four times the original volume of red cells used. 
The 0.1 N HC1 used was made up by diluting reagent grade concentrated HC1 with pyrogen- 
free, sterile, distilled water. 
Removal of Excess Potassium.--Without removing the suspended precipitate, the mixture 
obtained by the above acidification was treated with sodium zeolite (decalso), to reduce, by 
ion exchange for Na,  the potassium concentration  to a  physiological plasma level.  The 
decalso, 50 to 80 mesh, was first washed with 5 per cent NaC1  solution, dried, andheat- 
sterilized.  3  Thirty grams of this decalso were added per liter of cell solution, and the mixture 
was gently stirred several times to insure adequate mixing.  Exchange of potassium of the 
solution with sodium of the decalso approached equilibrium in a few minutes, ~ and, with the 
amount of decalso used, the concentration of potassium in the treated solution was lowered to 
approximately 4  milliequivaients per liter. 
After the addition of decalso, the mixture was let stand for 1 hour to allow maximum aggre- 
gation of the bulky, almost granular precipitate and then the decalso and previously pre- 
cipitated stroma were removed together by filtration through  a  coarse filter paper.  The 
filtrate volume approximated 70 per cent of the volume of mixture filtered; the yield by cen- 
trifugation was not found sufficiently greater to compensate for using it in place of filtration. 
Adjustment to Final pH and Electrolyte Content.--The  clear deep red filtrate o.f pH 5.7 to 5.8 
contained approximately 4 miUiequivalents  of potassium and 30 milliequivalents of sodium per 
liter, chiefly as the chlorides.  Solid sodium bicarbonate was added to the solution in an 
amount sufficiently in excess of the previously added HC1 to provide a final concentration of 
The authors are greatly indebted to Dr. Csnby Robinson of the American Red Cross for 
permission to use discarded red blood cell residues, and to Dr. Boynton of the American Red 
Cross for constant effort to insure that an adequate supply of fresh cell residues was main- 
rained to this laboratory. 
s Decalso, trade name for a synthetic sodium-aluminum-silicate zeolite, manufactured and 
obtained from the Permutit  Company, 330  West 42nd  Street,  New York  18,  New York. 
Drying and heat sterilizing decalso for 1 hour at 160  ° to 170°C. apparently causes some 
d~miuution  in its effectiveness in exchanging sodium for potassium; the 30 gin. per liter of 
solution recommended allows for this slight loss of activity. 
4 That potassium is exchanged for sodium, atom for atom, was established by analysis of 
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20 millimolar bicarbonate.  In addition, enough solid sodium chloride was added to bring  the 
final concentration of sodium to approximately 145 milliequivalents per liter, and sufficient 
calcium and magnesium as chlorides to give concentrations of 5 and 2 milliequlvalents per 
liter respectively.  The pH of the final solution usually lay between 7.1 and 7.6, depending 
on the residual amount  of carbon dioxide liberated  by reaction with the HC1.  A sample of the 
filtrate was taken for sterility tests. 
S~rilizoJion by Seitz Filtra~ion.--The  solution was filtered through a Seitz filter using an 
S-1 filter pad under 15 to 20 pounds pressure per square inch.  Filtration was rapid; 2 liters 
filter through a pad 120 ram. in diameter in about 15 to 20 minutes.  Passage through the 
Seitz filter also insured removal of any precipitated  stroma and zeolite that might not have 
been removed in the first tilt.ration.  The solution was conveniently filtered into 500 ml. or 
liter bottles, which were then dosed with sterile rubber stoppers and kept at 4°C., until  used. 
Portions of the filtrate  were taken for sterility and pyrogen tests and additional tests for 
sterility were done on a number of individual  bottles after varying  periods of storage. 
Properties of the Hemoglobin Solutions 
Composition  and  Physical  Properties.--Solutions  of  hemoglobin  prepared 
according to the method just described were clear, of deep red color, and con- 
tained approximately 7 gin. of hemoglobin per 100 ml.  If the entire procedure 
was carried out at 4°C., 95  to 98 per cent of the hemoglobin was active.  If 
the procedure was carried out at room temperature with solutions previously 
chilled to 4°C., and removed from the refrigerator as used, the percentage of 
active hemoglobin was  slightly lower,  92  to  95  per cent.  Analysis for  lipid 
carbon showed that 90 to 95 per cent of all lipids had been removed.  Numer- 
ous tests of human hemoglobin solutions mixed with human blood cells of all 
four types have never shown any red cell agglutinating properties.  No par- 
ticulate material could be detected on dark field illumination.  In the absence 
of  evaporation when kept at 4°C., the solutions remained free of precipitate 
for 6  months or longer.  Some solutions utimately developed small amounts 
of a fine reddish precipitate which was observed only after standing 6 months 
or longer; the formation of precipitate is discussed below. 
t 
Stability of Solutions Stored at Various Temperatures.- 
Ten ml. portions of a hemoglobin solution were transferred with a sterile pipette into 20 
mi. sterile pyrex glass ampules, and the ampules sealed in the oxygen flame.  Sealed  ampules 
were stored at 4°C., at 20-25°C. (room temperature),  and at 38°C. respectively.  From time 
to time up to 47 days, ampules stored at these temperatures were opened and analyzed for 
total and active hemoglobin.  The results are shown in Fig. 1.  It will be seen from these data 
that the solutions were completely stable at 4°C. but that at room temperature  methemo- 
globin (total--active hemoglobin) formation was appreciable, and that it was still faster at 
38°C.  It was observed that the formation of precipitate in the solution also depended upon 
the temperature  of storage.  Considerable precipitate slowly formed in the solutions stored 
at 38°C., less in those stored at room temperature, and none  was formed in the solutions stored 
at 4°C. over the 47 day period.  Solutions stored under CO2 at room temperature showed more 
precipitate than those stored under air at the same temperature. 
Two ampules after 6 months' storage at 4°C. showed 3 and 15 per cent formation of meth- 
emoglobin respectively.  One ampule of hemoglobin solution in which 99.7 per cent of the HAMILTON~ I~ARR, HILLER~ AND VAN  SLYKE  459 
active hemoglobin had been deoxygenated by removal of 02 before the ampule was sealed 
showed  no change in methemoglobin or active hemoglobin after 6 months' storage at 4°C. 
None  of these ampules had developed any sediment in the 6 months' storage period. 
Other stability experiments were carried out on 200 cc. lots of hemoglobin solution stored 
at 4°C. in sterile bottles closed with rubber stoppers.  Samples of solution were removed with 
aseptic precautions at weekly intervals and analyzed for total and active hemoglobin.  No 
methemoglobin formation was observed over a period of 10 weeks; and no sediment was ob- 
served at the end of 6 months.~ 
From these experiments it appears that no methemoglobin is formed over a 
period of 2½ months; over a 6 month period a  small and variable amount of 
methemoglobin may  be  formed.  Dr.  R.  B.  Pennell of  Sharp  and  Dohme 
Company  s has informed the authors that he has succeeded in storing solutions 
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Decrease in activity of hemoglobin in solutions standing  at different temperatures. 
months without detectable methemoglobin formation and without any pre- 
cipitate formation providing the solutions were kept frozen solid at tempera- 
tures of  -5 °  to O°C.  It therefore appears probable that the methemoglobin 
and sediment formation observed in our experiments was due to storage at too 
5 Anomalous behavior was occasionally noted in a bottle d  the thirty or forty that were 
nsually filled from one preparation.  Some  of these bottles exhibiting anomalous behavior 
showed on storage fairly rapid conversion of hemoglobin to met.hemoglobin  which on further 
storage showed slow spontaneous reconversion to active deoxygenated hemoglobin.  Other 
bottles exhibited consumption of oxygen with the formation of deoxygenated hemoglobin  with- 
out previous conversion to methemoglobin.  These changes were always visibly evident, the 
solution becoming brown with the formation of methemoglobin, and a deep purple hue with the 
formation  of  the deoxygenated hemoglobin.  Examination  of these  bottles  that behaved 
anomalously never revealed bacterial contamination. 
6 The authors are indebted to Dr. R. B. Pennell  d  Sharp and Dohme Company, Glenolden, 
Pennsylvania,  for much helpful information which he has freely placed at our disposal through- 
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high a temperature; the minimum temperature of our storage facilities was 4°C., 
in refrigerators that were opened frequently and which did in fact suffer con- 
siderable elevations of temperature above this minimum as a  result of tempo- 
rary interruption of refrigeration service. 
Effect of Storage under a COs Atmosphere.--Ten  ml. portions of hemoglobin 
solutions were  transferred,  with  precautions for sterility, to  a  few ampules 
which were then evacuated with a water pump and refilled with CO~ four times 
before sealing of the ampule.  These were stored at room temperature only. 
In these CO~-filled ampules, formation of methemoglobin was more rapid than 
in the air-filled ampules (Fig. 1).  This observation is in keeping with the find- 
ings of Brooks (27) who showed that at 25°C.  decrease of pH accelerates the 
conversion of hemoglobin to methemoglobin.  On  filling ampules with  CO2 
the pH was lowered from 7.6 to 6.8 or 7.0;  solutions in ampules sealed with 
air and stored had pH values of 7.3 to 7.6 when opened subsequently.  It is 
pertinent that Brooks (27) showed that the conversion of hemoglobin to met- 
hemoglobin by oxygen under these conditions was the only detectable reaction; 
i.e., he could not detect conversion of hemoglobin or methemoglobin to other 
denatured pigments. 
DISCUSSION 
The two major problems which had to be overcome in the preparation of 
these solutions were the complete removal of stroma and reduction of the potas- 
sittm content to a  concentration approximately that of normal plasma.  No 
adequate tests exist for the detection of stroma material, since the substance 
has not been sufficiently characterized chemically.  We found that simple ad- 
dition of salt to the laked cell suspension (8, 13, 15, 17, 18) did not remove all 
material precipitable by toluene or by acid at a pH of 5.9.  Cooling the laked 
cell suspension and bubbling carbon dioxide through it precipitated the stroma 
material, but the precipitate was so fine that frequently it was impossible to 
separate it by filtration from the solution, and it blocked a Seitz filter pad.  The 
CO2 treatment also increased  the proportion of methemoglobin.  Removal of 
stroma with aluminum hydroxide (28) was not found satisfactory.  Although 
toluene as used  by  Heidelberger (29)  and a  number of subsequent workers 
(2-4, 9, 16, 30), appears to remove stroma material quantitatively, the resulting 
solutions could be rendered free of toluene only with ditficulty  and uncertainly. 
Crystallization  of  hemoglobin  and  preparation  of  solutions  from  such 
crystallized material was avoided because of the extra steps involved, and be- 
cause hemoglobin crystallized by Heidelberger's method (29) has been found 
to contain 7 to 15 per cent of methemoglobin (31).  The acidification technique 
originally described by Jorpes (32)  for the isolation of stroma material was 
found to be efficient and easily adaptable to the present investgation.  How- 
ever,  it was found that if the HCI is added slowly as from a  burette with vig- H~rr.TON,  FARR,  HII,LER~ AND  VAN  SLYKE  461 
orous mechanical stirring a  very fine  precipitate forms,  presumably stroma, 
which is very difficult to centrifuge  down and  impossible  to filter off, even 
though the pH has been brought to 5.7  to 5.8.  If to this unfilterable  sus- 
pension of stroma material 1 to 5 per cent of acid-denatured hemoglobin is ad- 
ded rapid and complete flocculafion of the stroma occurs in a form that can be 
readily filtered  off.  Since the technique of acidification used in our prepara- 
tions produced an  easily filterable  precipitate it is inferred that  there must 
have been small amounts of acid-denatured hemoglobin formed on the addition 
of the HC1.  These observations indicate that adjustment to the isoelectric 
point of stroma is not the only factor involved in the precipitation of stroma 
on the addition of acid. 
Although removal of excess potassium in solutions  made from dog hemo~ 
globin is not necessary because of the low potassium content of red blood cells 
of the dog, it is required  with solutions made from human red blood cells, or 
the resulting solution will have a potassium content close to toxic levels (33) 
for plasma.  Ion exchange with sodium zeolite proved to be a rapid and eco- 
nomical means of reducing the K + concentration to normal physiological ]eve]s 
by replacement with Na  +. 
The importance of keeping bacterial contamln~tion and growth low hardly 
needs emphasis, for toxic substances are rapidly produced when bacteria multi- 
ply in solutions of hemoglobin.  Most investigators previously have preferred 
to prepare solutions for immediate use, sacrificing rigid aseptic  technique for 
speed of preparation and relying on low temperatures to retard bacterial growth 
till the moment of injection.  None have mentioned carry~mg out tests for 
pymgenic substances,  and in the absence of such tests it is difl~cnlt to assay 
reactions,  such as chills and fever,  which have been reported to follow intra- 
venous administration of hemoglobin solutions into human subjects (13, 15-18). 
Deoxygenated homoglobin provides a more stable form than oxyhemoglobin 
for storage in solution.  However, complete  deoxygenation  is a long and tedious 
process, and since the oxyhemoglobin solutions have been found to be stable 
at 4°C. over a period of at least 6 months, we do not believe that the advantages 
to be gained by deoxygenation  are equivalent to the increased labor of prepara- 
tion.  Hemoglobin  solutions  prepared for freezing and drying must be com- 
pletely deoxygenated, as noted in the accompanying paper  (34) to prevent 
methemoglobin formation during the process of dehydrating  the frozen mixture. 
SD'M~LRy 
A procedure  has been detailed for the preparation of sterile non-pyrogenic 
solutions  of oxyhemoglobin which have the approximate protein content and 
electrolyte composition of plasma, 
Large volumes of solution can be rapidly prepared, with 95 to 98 per cent of 
the hemoglobin  in the active form capable  of combining  with oxygen.  The 462  HEMOGLOBIN SOLUTIONS 
solutions contain  no particulate  matter;  95 per cent of total blood lipids are 
removed. 
Solutions stored at 4°C. showed no conversion of hemoglobin to methemo- 
globin over a period of 2½ months; over a 6 month period a small and variable 
amount of methemoglobin may be formed. 
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